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Background: The lack of a safe and effective adult worm drug and the emergence of resistant animal parasite
strains to the only recommended drug, the microfilaricide, ivermectin put many at risk of the devastating effects
of the onchocerciasis. The present study was undertaken to investigate the acclaimed anti-Onchocerca activity of
the roots/rhizomes of Cyperus articulatus in the traditional treatment of onchocerciasis in North Western Cameroon
and to assess the plant as a new source of potential filaricidal lead compounds.
Methods: Crude extracts were prepared from the dried plant parts using hexane, methylene chloride and
methanol. The antifilarial activity was evaluated in vitro on microfilariae (Mfs) and adult worms of the bovine
derived Onchocerca ochengi, a close relative of Onchocerca volvulus. The viabilities of microfilariae and adult male
worms were determined based on motility reduction, while for the adult female worms the viability was based on
the standard MTT/formazan assay. Cytotoxicity of the active extract was assessed on monkey kidney epithelial cells
in vitro and the selectivity indices (SI) were determined. Acute toxicity of the promising extract was investigated in
mice. Chemical composition of the active extract was unraveled by GC/MS analysis.
Results: Only the hexane extract, an essential oil exhibited anti-Onchocerca activity. The oil killed both the microfilariae
and adult worms of O. ochengi in a dose manner dependently, with IC50s of 23.4 μg/ml on the Mfs, 23.4 μg/ml on adult
male worms and 31.25 μg/ml on the adult female worms. Selectivity indices were 4, 4, and 2.99 for Mfs, adult males
and adult females, respectively. At a single limit dose of 2000 mg/kg body weight, none of 6 mice that received
the essential oil by gavage died. GC/MS analysis revealed the presence of terpenoids, hydrocarbons and fatty acids
or fatty acid derivatives as components of the oil.
Conclusions: The essential oil from the roots/rhizomes of Cyperus articulatus is active against O. ochengi
microfilariae and adult worms in vitro in a dose dependent manner, hence may provide a source of new
anti-filarial compounds. The results also support the traditional use of C. articulatus in the treatment of human
onchocerciasis.
Keywords: Essential oil, Human onchocerciasis, Cyperus articulatus, Phytochemical analysis* Correspondence: chongwa_ub@yahoo.co.uk
1ANDI Centre of Excellence, Biotechnology Unit, Faculty of Science,
University of Buea, P.O. Box 63, Buea, Cameroon
Full list of author information is available at the end of the article
© 2014 Metuge et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Metuge et al. BMC Complementary and Alternative Medicine 2014, 14:223 Page 2 of 10
http://www.biomedcentral.com/1472-6882/14/223Background
Onchocerciasis or river blindness is the second leading
infectious cause of blindness in humans. According to
the World Health Organization, an estimated 37 million
people are infected with the parasite and about 300,000
are blind from onchocerciasis [1]. Ivermectin was shown
to be both safe and effective in the treatment of oncho-
cerciasis and has become the drug of choice for control
by mass drug administration (MDA) strategy [2]. How-
ever, ivermectin is only effective against the microfilarial
stage (Mfs) of the parasite and prolonged annual ivermec-
tin therapy of at least 10 to 15 years has been predicted to
be required for clearance of onchocerciasis from a human
population [3]. This makes the search for a drug that kills
the adult worm (a cure) a research priority area. During
mass treatment of onchocerciasis with ivermectin in
forested zones of Central Africa, several adverse events,
including encephalopathy and deaths were reported in
patients co-infected with L. loa [4]. The potential deve-
lopment of ivermectin-resistant strains of the parasite
also demands the identification of alternative drug
candidates for onchocerciasis control [5].
A new chemotherapeutic approach to onchocerciasis
uses antibiotics against the essential Wolbachia endo-
bacteria present in many filariae. Doxycycline has been
shown to exhibit a macrofilaricidal effect on O. volvulus
after a daily dosage for six weeks [6]. Although a report
on community-directed delivery of doxycycline for the
treatment of onchocerciasis in Cameroon indicated that
delivery and compliance are achievable for six weeks [7],
it must be recognized that there are restrictions on the
use of this antibiotic on pregnant women, lactating mothers
and children less than 9 years of age [8].
It has been suggested that natural plant products may
provide a good alternative source of antifilarial medicines
because they are cheap, readily available, have negligible
side effects [9,10] and compliance rate may be high since
they are indigenous medicines. Natural products have
shown great potentials in treating infectious diseases in
humans [11]. Studies on the chemical composition and
biological activity of Cyperus articulatus suggest that rhi-
zomes of the plant have anti-plasmodial, antibacterial,
anti-fungal, as well as anti-convulsant actions [12-15].
However, the anti-onchocercal activity of C. articulatus
has not been evaluated. It is against this backdrop that this
study was aimed at evaluating the antifilarial activity of
the roots and rhizomes of Cyperus articulatus, a plant
used in the traditional treatment of onchocerciasis in
North Western Cameroon. In its local use, the roots and
rhizomes of the plant are chopped, dried, boiled in water
and taken as a decoction. The activity was evaluated on
the Mfs and adult worms of Onchocerca ochengi, the
closest relative of O. volvulus and best model for anti-O.
volvulus drug screens [16].Methods
Collection and identification of plant
The roots and rhizomes of Cyperus articulatus were
collected from inland valleys at Sehn village, Ndu Sub-
Division in the North West Region of Cameroon in
February 2012, based on ethnopharmacological informa-
tion. The local name of the plant is “Ndfu”. The voucher
specimen was deposited at the National Herbarium in
Yaoundé and assigned voucher number 19450/SRF-CAM.Preparation of plant extracts
The roots along with the rhizomes of Cyperus articulatus
were air-dried for three weeks and ground to fine powder.
The powder was weighed and macerated for 48 hours,
three times per solvent and sequentially in hexane, methy-
lene chloride and methanol, following increasing solvent
polarity. The mixture was filtered and the filtrate concen-
trated under reduced pressure using a rotary evaporator
(BUCHI Rotavapor R-200, Switzerland) set at 150 mbar.
The hexane and methanol extracts were concentrated
under reduced pressure at 45°C while the methylene
chloride extract was concentrated at 50°C without the
pressure reduction. Residual solvent was removed by
drying in air at room temperature (23 - 25°C) for 6 days.
The extracts were weighed and stored at −20°C until
used.Isolation of O. ochengi adult worms
The isolation of O. ochengi adult worms was done as de-
scribed previously [17]. The duration from the slaugh-
tering of a cow to the harvesting of parasites from the
skin was always less than 2 hours to ensure full parasite
viability. Briefly, fresh pieces of umbilical cattle skin
with palpable nodules bought from local slaughter-
houses were washed, drained and sterilized with 70%
ethanol. O. ochengi adult worms were carefully scraped
out of the nodules as single masses and temporarily
submerged in 1 mL complete culture medium, CCM
[RPMI-1640 (SIGMA, USA) supplemented with 25 mM
HEPES, 2 g/L sodium bicarbonate, 2 mM L-glutamine,
5% new born calf serum (SIGMA, USA), 150 units/mL
penicillin, 150 μg/mL streptomycin and 0.5 μg/mL
amphotericin B (SIGMA, USA), pH 7.4)] using 24-well
plates. The adult worms were allowed in the culture
medium overnight in a CO2 incubator, during which
period the male worms migrated out of the nodular
masses. Only wells containing viable worms received
treatment with the plant extract. Worms from putrefied
nodules were discarded. The viability of worms retained
for the assay was ascertained by visual and microscopic
examination of adult worm and microfilarial motility
using an inverted microscope.
Metuge et al. BMC Complementary and Alternative Medicine 2014, 14:223 Page 3 of 10
http://www.biomedcentral.com/1472-6882/14/223Isolation of O. ochengi microfilariae
The cattle skin was obtained as described for adult worms.
About 5 skin snips were obtained from different locations
of the skin and incubated separately in small amounts of
CCM for 30 minutes. Emerged Mfs were qualified and
quantified for O. ochengi species with the aid of an
inverted microscope. A selected piece of skin, rich in O.
ochengi Mfs was carefully shaved with a razor blade and
rinsed with distilled water. It was dabbed with a clean
tea cloth to eliminate excess moisture and covered
entirely with 70% ethanol. The latter was allowed to
evaporate completely in a horizontal flow sterile hood.
The ethanol treatment was repeated once. The sterilized
skin was tautly attached onto an autoclaved, cylindrical
piece of wood using autoclaved thumb nails and close
(about 1 mm apart) criss-cross cuts were made into the
epidermis and dermis. The assembly was incubated in the
culture medium for 4–6 hours. The emerged and highly
motile O. ochengi microfilariae were concentrated by cen-
trifugation at 400 × g for 10 minutes and then quantified.
Preparation of mammalian cells
Monkey kidney epithelial cells (LLC-MK2) (ATCC, USA)
were cultured at 37°C in humidified air with 5% CO2 in a
HeraCell-150 incubator (Thermo Electron, Germany)
until the cell layer was almost confluent. The cells were
rinsed with a solution of 0.125% trypsin and 0.5 mM
EDTA in medium 199 (Sigma, USA) and kept in the same
mixture for less than 1 hour for them to be dislodged. The
cell suspension was centrifuged at 560 × g for 10 minutes,
the supernatant discarded and the pellet re-suspended to
2 × 105 cells/ml in CCM. The cell suspension was
dispensed into 96-well microtitre plates (200 μl/well) and
kept in the incubator for 3–5 days for cells to grow and be-
come fully confluent. These cells served as feeder layer for
the Mfs assays and were also used for cytotoxicity studies.
Preparation of stock solutions of plant extracts
Twenty-five milligrams (25 mg) of each crude extract
was weighed and dissolved in microtubes containing
1 mL of 99.9% pure dimethyl sulfoxide (DMSO) (SIGMA,
USA) to obtain stock solutions of 25 mg/mL. Complete
dissolution was achieved by vortexing. The solutions were
stored at 4°C for a maximum of one week before they
were used in the assays or were stored frozen at −20°C
in convenient aliquots prior to use.
Anti-filarial screening of plant extracts
Primary screens on adult worms
This was done to eliminate inactive extracts. Adult
worm assays were conducted in 24-well plates (NUNC,
USA) at 37°C in humidified air containing 5% CO2 for
5 days (120 hours) without change of medium. Nodular
worm masses (each generally containing a few males anda female worm) were first put in the wells (with 1 ml
CCM at the time of worm isolation) without drug. One
(1) ml of CCM containing 1 mg/ml of extract was then
added into each of quadruplicate wells to give a single final
concentration of 500 μg/ml. Four nodular worm masses
each, were used in the negative control (2% DMSO in
CCM only) and in the positive control (10 μM NYBC01, a
gold conjugated compound) wells in which each well also
received only one nodular worm mass. After 5 days incu-
bation, adult male worm viability was assessed based on
motility scores using an inverted microscope. Motility
score was on a scale of 4 (vigorous or normal movement
of whole worm, corresponding to 0% inhibition of worm
motility), 3 (near normal movement of whole worm or
25% inhibition of worm motility), 2 (whole body of worm
motile but sluggish i.e. 50% inhibition of worm motility), 1
(only head or tail of worm moving i.e. 75% inhibition of
worm motility), 0 (completely immotile worm i.e. 100%
inhibition of worm motility). An extract was considered ac-
tive on the adult male worm if there was a 100% inhibition
of motility; or moderately active for a motility inhibition of
50 - 99%; and inactive if the inhibition was less than 50%.
Adult female worm viability was assessed by the MTT/
formazan assay [18] in which each nodular worm mass was
placed in a well of a 48-well microtitre plate containing
500 μl/well of 0.5 mg/ml MTT (Sigma, USA) in incomplete
RPMI culture medium, and then incubated in the dark at
37°C for 30 minutes. Adult female worm viability was taken
as mean % inhibition of formazan formation relative to
negative control at 120 h post addition of plant extract. An
extract was considered active on the adult female worm if
there was a 90 % or greater inhibition of formazan forma-
tion compared to the negative controls; or moderately active
if the inhibition was 50 - 89%. It was considered inactive if
the inhibition was less than 50%. Adult worm death posi-
tively correlates with inhibition of formazan formation.
Primary screen on microfilariae
The extracts were also tested on Mfs at a single concen-
tration of 500 μg/ml, in duplicate wells. The Mfs assay
was conducted in 96-well microtitre plates (15 mfs in
200 μl CCM per well) at 37°C in humidified air contain-
ing 5% CO2 for 5 days without any change of medium.
Fully confluent monkey kidney epithelial cells, serving as
feeder layer, were co-cultured with the Mfs. The medium
used in preparing the feeder cell layer was removed by a
swift decantation before fresh CCM containing plant
extract (100 μl) and worms (100 μl) were immediately
added. Ivermectin (20 μg/mL) and 2% DMSO served as
the positive and negative controls respectively. Mfs mo-
tility reduction (viability reduction) were done on a scale
of 100% (immotile), through 75% (only tail or head shak-
ing occasionally), through 50% (whole body motile, but
sluggishly or with difficulties), to 25% (almost vigorous)
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24 h, terminating at 120 h using an inverted microscope.
Any culture with microbial contamination was not
considered. Mfs viability was taken as the mean %
reduction at 120 h (day 5) after addition of drug. An
extract was considered active if there was a 100%
reduction in mfs motility; or moderately active for a
motility reduction of 50 - 99%; and inactive if the
reduction was less than 50%.
Secondary screens on microfilariae and adult worms
This was done to confirm the activity of active extracts
and to determine their IC50, IC100 and selectivity index
(SI) values. The extracts were retested as described under
primary screens at serial dilutions from 500 to 7.81 μg/ml.
All assays were repeated at least thrice and the results
obtained are the mean values at each concentration.
The graphical analyses and IC50 values were determined
using GraphPad Prism software (version 6).
Toxicity studies
Cytotoxicity studies
This was done as part of the Mfs assay on the active
extracts through observations on the monkey kidney
epithelial cells on day 5. An examination of the defor-
mities and degree of detachment of the monkey kidney
cells was done. Dead or deformed cells were usually
detached from the bottom of the vessel and were
rounded in shape. The IC50 values for these mammalian
cells were determined graphically using data from
microscopy. The selectivity index (SI) values were calcu-
lated using the ratio:
SI ¼ IC50 of drugonmammaliancell=IC50 of drugonparasite Mfsð Þ
Acute toxicity test
This test was conducted in accordance with the Organisation
for Economic Co-operation and Development (OECD)
Guidelines for the Testing of Chemicals [19]. Briefly, six
(6) nulliparous and non-pregnant female Balb/c mice,
about 10 weeks old (averagely 20 g each) were kept in
their cages for 5 days prior to dosing to allow for
acclimatization to the animal house conditions. Food,
but not water was withheld for 4 hours after which, theTable 1 Yield of extracts of roots/rhizomes of C. articulatus us
Name of plant Plant part used Mass of dry powder or
residue (approx.)/g
Cyperus articulatus Root/rhizome 700
673.8
668
*The extract code CAR represents roots/rhizomes of Cyperus articulatus while the lo
methylene chloride and methanol, respectively. CARhex is the essential oil.animals were weighed and the extract was administered
orally by gavage at a limit dose of 2000 mg/kg body
weight in a volume of 1 ml/100 g of body weight of
mouse. The oil (active hexane extract) was dissolved in
100% hybrimax™ DMSO (SIGMA USA) and diluted
with sterile distilled water to give 2% DMSO solution.
For negative control, six female mice were similarly
dosed with 2% DMSO diluted in sterile distilled water.
After the test substance was administered, food was
withheld for a further 2 hours. The animals were ob-
served individually after dosing, once every 30 minutes
during the first 4 hours, and daily thereafter for a total
of 14 days. The animals were weighed every two days
and observed for physical activity and behavior pattern,
food and water intake, changes in skin and fur, eyes and
mucous membranes, tremors, convulsions, diarrhea,
salivation, lethargy, sleep, coma and death.
Gas chromatography–mass spectrometry (GC/MS) analysis
The essential oil was subjected to GC-MS analysis for
phytochemical studies. The GC/MS spectrometer (Agilent
6890/Hewlett-Packard 5975) was fitted with electron
ionization (EI) module. Helium was used as the carrier gas
at a flow rate of 1 ml/min. The temperature was pro-
grammed at 80°C for 5 min then increased to 300°C at
the rate of 15°C/min. The temperatures of the injector
and EI detector (70 eV) were 280°C and 300°C, respec-
tively. Then 29 μl of the essential oil were injected into
the fully calibrated GC/MS spectrometer. The compound
identification was based on the comparison of the reten-
tion indices (determined relative to the retention times
of series of n-alkanes), using an online natural products
library.
Results
Preparation of plant extracts
Table 1 summarizes the percentage recovery of the diffe-
rent extracts of the roots/rhizomes of C. articulatus. The
hexane extract (CARhex) was an essential oil, while the
methylene chloride and methanol extracts were solids.
Activity of extracts of roots/rhizomes C. articulatus in
primary screens
At 500 μg/ml, only the essential oil was active against






Hexane 26.2 3.74 *CARhex
Methylene chloride 5.8 0.86 CARmc
Methanol 72.2 10.8 CARmet
wer case letters of the code, hex, mc and met represent the solvents, hexane,










CARhex (500 μg/ml) 100 100 100 Macro- and microfilaricidal
CARmc (500 μg/ml) 25 50 25 Inactive
CARmet (500 μg/ml) 25 75 25 Inactive on Mfs and adult females;
moderately active on adult males
Ivermectin (10 μg/ml) 100 NA NA Microfilaricidal
NYBC01 (10 μM) 100 100 100 Macro- and microfilaricidal
DMSO (2%) 0 0 0 Inactive
NA = Not applicable.
The gold-conjugated compound, NYBC01 was used as positive control for adult worm assay, while ivermectin was similarly used in the microfilarial assay. The drug
diluent, 2% dimethyl sulphoxide (DMSO) was used as negative control.
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after 24 hours incubation, and produced 100% inhibition
of formazan formation in adult female worms at 120 hours
incubation. At 10 μM, NYBC01, a gold conjugated
compound served as the positive control.Figure 1 Effect of concentration of the essential oil of C. articulatus
cultures were determined in the presence of different concentrations of
(b) and inhibition of formazan formation (corresponding to worm death
determined.Activity of the essential oil in secondary screens and
cytotoxicity test
The essential oil inhibited O. ochengi Mf and adult male
worm motility, as well formazan formation by adult female
worms in a dose dependent manner (Figure 1a-c).(CARhex) on O. ochengi viability. The viabilities of parasites in
the essential oil. Microfilarial motility (a), adult male worm motility
) in adult female worms (c) after 120 hours incubation were
Table 3 IC50, IC100 and Selectivity Indices (SI) of the
essential oil on O. ochengi








IC50 (μg/ml) 23.4 23.4 31.25 93.7
IC100 (μg/ml) 62.5 62.5 125 250
SI = IC50 MKC/IC50
worm
4.0 4.0 2.99 -
SI (Selectivity Index) = IC50 on mammalian cells/ IC50 on parasite.
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O. ochengi microfilariae and adult worms, and the mon-
key kidney cells, indicating the inhibitory concentration
(IC) and selectivity index (SI) values. The oil was mo-
derately cytotoxic on the monkey kidney cells.
Acute oral toxicity test of the essential oil in mice
Figure 2 shows the effect of the essential oil on the mean
weight of six Balb/c mice after limit dosing by gavage
(2000 mg/kg body weight). Only one out of the six mice
dosed with the oil had rough fur, lost weight slightly and
initially and then started gaining weight 4 days after the
extract administration. All other mice dosed with the
essential oil were active and healthy and gained weight
continuously. Individual cage-side observations showed
no other abnormalities. No mouse died during follow-up
for14 days. All the mice given 2% DMSO in distilled
water (control group) gained weight continuously.
GC/MS analysis of the essential oil
Table 4 gives the chemical composition of the essential oil
of the roots/rhizomes of C. articulatus. GC/MS analysis
revealed more than 80 compounds with monoterpenes,Figure 2 Effect of essential oil of C. articulatus (CARhex) on Balb/c mic
dose of 2000 mg/kg body weight of mouse were determined over a 14 da
diluent (2% DMSO) only.sesquiterpenes, hydrocarbons, fatty acids and fatty acid
derivatives being the most abundant.
Discussion
The present study was carried out to investigate the
acclaimed antifilarial activity of roots and rhizomes of
Cyperus articulatus in the traditional treatment of on-
chocerciasis in North Western Cameroon and to assess
the potential of the plant as a new source of novel
O. volvulus filaricidal lead compounds. Solvents of increas-
ing polarity (hexane, methylene chloride and methanol)
were sequentially used to produce three crude extracts
from the roots/rhizomes of C. articulatus. The hexane
extract (an essential oil) was the most active, showing
activity against microfilariae and adult worms in a dose
dependent manner. The oil was apparently more active
against adult males (IC50 = 23.4 μg/ml) than adult females
(IC50 = 31.25 μg/ml) (Table 3), probably because motility
reduction (used in assessing the males) is different from
biochemical death (used in assessing the females).
This activity shows that the roots/rhizomes contain
anti-Onchocerca principles and justifies their use in the
traditional treatment of human onchocerciasis in the
area. Thus, a search for novel filaricides from the plant
materials should be focused on the non-polar extract.
This is in contrast to the practice by herbalists who use
the polar solvent, water in preparing the decoctions, in-
dicating that their extraction procedure may be grossly
inefficient [20]. The use of oils in extraction (assuming
compounds remain stable) or addition of edible oils in
preparation of the decoction may improve on yield and
overall efficacy in the traditional medicine practice. Most
herbalists around the world rely heavily on use of the uni-
versally available and safe solvent, water in the preparatione. The mean weights of six mice after administration of a single limit
y period. The negative control mice (6 animals) were dosed with
Table 4 Chemical composition of essential oil (hexane extract) from roots/rhizomes of C. Articulatus
Monoterpenes
Compound (Chemical name) Retention time (RT) min Nature of compound
Camphenol, 6- 4.4913 Monoterpene alcohol
Bicyclo[3.1.1 ]heptan-3-ol, 6,6-dimethyl-2-methylene-, [1S-(1 à,3à,5à)]- 4.7638 -do-
Bicyclo[3.1.1 ]hept-3-en-2-ol, 4,6,6-trimethyl-, [1S-(1 à,2a,5à)]- 4.8523 -do-
Bicyclo[3.1.0]hexan-3-ol, 4-methylene-1-(1-methylethyl)-, [1.S-(1 à,3a,5à)]- 4.9535 -do-
(−)-Myrtenol 5.8193 -do-
Bicyclo[3.1.0]hex-3-en-2-one, 4-methyl-1-(1-methylethyl)- 6.0775 Monoterpene ketone
Bicyclo[3.1.1 ]hept-3-en-2-one, 4,6,6-trimethyl-,(1S)- 6.0815 -do-
3,5-Heptadienal, 2-ethylidene-6-methyl- 6.2340 Monoterpene aldehyde
Bicyclo[4.4.0]dec-2-ene-4-01, 2-methyl-9-(prop-1-en-3-01-2-yl)- 15.8243
Sesquiterpenes




7-Tetracyclo[6.2.1.0(3.8)O(3.9)]undecanol, 4,4,11,11-tetramethyl- 11.0275 Sesquiterpene alcohol
Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-7 -methyl-4-methylene-1-(1-methylethyl)-, (1à,4aà,8aà)- 11.1640
Naphthalene, 1,2,3,4-tetrahydro-1 ,6-dimethyl-4-(1-methylethyl)-, (1S-cis)- 11.2919
(+)-Epi-bicyclosesquipheliandrene 11.5152
2,3,4-Trifluorobenzoic acid, 4-nitrophenyl ester 11.6408
7-Tetracyclo[6.2.1.0(3.8)0(3.9)]undecanol, 4,4,11,11-tetramethyl- 11.7243 Sesquiterpene alcohol
2-Naphthalenemethanol, 1,2,3,4,4a ,8a-hexahydro-à, à,4a, 8-tetramethyl-, [2R-(2à,4aà,8aà)]- 11.7325 -do-
Cycloisolongifolene, 8,9-dehydro- 12.2912
Caryophyllene oxide 13.2509 Sesquiterpene oxide
Longipinocarvone 13.7303
3-lsopropyl-6, 7-dimethyltricycio[4.4.0.0(2,8)]decane-9, 1O-diol 13.7752 Sesquiterpene alcohol
Compound (Chemical name) Retention time (RT) min Nature of compound
Sesquiterpenes (cont’d)
cis-Z-α-Bisabolene epoxide 14.0907 Sesquiterpene epoxide
Longiverbenone 14.9277
2,2,7,7 -Tetramethyltricyclo[6.2.1.0(1 ,6)]undec-4-en-3-one 15.6833 Sesquiterpene ketone
Acetic acid, 3-hyd roxy-6-isopropenyl-4, 8a-dimethyl-1 ,2,3,5,6,7,8,
8aoctahydronaphthalen-2-yl ester
15.7474 Sesquiterpene ester
5( 1H)-Azulenone, 2,4,6,7,8, 8a-hexahydro-3, 8-dimethyl-4-( 1-methylethylidene)-, (8S-cis)- 15.7488
Perhydrocyclopropa[e]azulene-4,5,6-triol, 1,1 ,4,6-tetramethyl 15.8186
1 H-Cycloprop[e]azulen-7 -01, decahydro-1 ,1,7 -trimethyl-4-methylene-,
[1ar-(1 aà,4aà,7a,7aa,7bà)]-
15.8686
(−)-Spathulenol 15.8706 Sesquiterpene alcohol
Corymbolone 15.9639 Sesquiterpene
ketoalcohol
Spiro[4.5]decan-7 -one, 1,8-dimethyl-8,9-epoxy-4-isopropyl- 16.1027 Sesquiterpene ketone
9H-Cycioisolongifolene, 8-oxo- 16.2514
2( 1H) Naphthalenone, 3,5,6,7,8, 8a-hexahyd ro-4, 8adimethyl-6-( 1-methylethenyl)- 16.2630 Sesquiterpene ketone
E-15-Heptadecenal 16.4377 Sesquiterpene aldehyde
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Table 4 Chemical composition of essential oil (hexane extract) from roots/rhizomes of C. Articulatus (Continued)
6-lsopropenyl-4,8a-dimethyl-1 ,2,3,5,6,7,8,8aoctahydronaphthalene-2,3-diol 16.4982 Sesquiterpene alcohol
2( 1H)-Naphthalenone, 4a,5,6, 7, 8,8a-hexahydro-6-[1-(hydroxymethyl)ethenyl]-4,8adimethyl-,
[4ar-(4aà,6à,8aà)]-
18.5973 Sesquiterpene ketone





Compound (Chemical name) Retention time (RT) min Nature of compound
Hydrocarbons
2,6-Dimethyl-1 ,3,5,7-octatetraene, E, E- 3.0988 Unsaturated hydrocarbon
Benzene, 1-methyl-3-(1-methylethyl)- 3.1698 Aromatic hydrocarbon
1 H-Cycloprop[e]azulene, 1a,2,3,4,4a,5,6, 7boctahydro-1 ,1,4,7 -tetramethyl-, [1aR-(1aà,4à,4aa,
7bà)]-
9.7772 -do-
3H-3a, 7-Methanoazulene, 2,4,5,6,7 ,8-hexahydro-1,4,9,9-tetramethyl-, [3aR-(3aà,4a,7à)]- 9.8550 -do-
Benzene, 1-(1 ,5-dimethyl-4-hexenyl)-4-methyl- 10.1253 -do-
Benzene, 1-methyl-4-(1 ,2,2-trimethylcyclopentyl)-,(R)- 10.3648 -do-





n-Hexadecanoic acid 19.4351 Palmitic acid
9, 12-0ctadecadienoic acid (Z, Z)- 21.5769 Linoleic acid
cis-13-0ctadecenoic acid 21.6267





Isophthalic acid, di(2-methylprop-2-en-1-yl) ester 11.5878
Myrtenyl acetate 23.3973
Trichloroacetic acid, hexadecyl ester 24.0485
Bis(2-ethylhexyl)phthalate 25.8520
Oodecanoic acid, dodecyl ester 26.0201
(−)-trans-Pinocarvyl acetate 27.9163
Oodecanoic acid, tetradecyl ester 28.0778
Oodecanoic acid, hexadecyl ester 30.1824
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http://www.biomedcentral.com/1472-6882/14/223of medicinal decoctions. This is one important limitation
of traditional medicine – irrationality, leading also to fre-
quent lack of standardization in the medicines. Thus, it
may not be surprising that despite the widespread use of
traditional medicine in developing countries, Neglected
Tropical Diseases like onchocerciasis continue to increase
in prevalence and intensity in some areas. On the other
hand, there exist many substances that show activityin vivo without being active in vitro. Such substances may
be extractable using the aqueous solvents.
Phytochemical analysis of the essential oil showed that
it contained a wide range of secondary metabolites:
monoterpenes, sesquiterpenes, hydrocarbons, fatty acids
and fatty acid derivatives (Table 4). Although the anti-
onchocercal activity of the essential oil cannot be
ascribed at this point to any of the compounds, a review
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http://www.biomedcentral.com/1472-6882/14/223by Kuete and Efferth [21] indicated that terpenoids from
Cameroonian plants showed best activities as anti-
parasitic agents. Nyasse and his group [22] also identi-
fied sesquiterpenes from C. articulatus collected from
Cameroon. Extracts from plants may provide a natural
combination of biologically active compounds respon-
sible for the death of the parasite. The different com-
pounds in the extract may be working in synergy to kill
the parasite by providing an arsenal to multiple drug
targets. For example, the present essential oil contains
corymbolone (a sesquiterpene) and spathulenol which
have been shown to exhibit anti-plasmodial [12] and an-
tifungal [23,24], activities, respectively. Further studies
are required to narrow down to the antifilarial principles
in the essential oil. Although single pure compounds may
inhibit particular molecular targets and even kill the para-
site, they may be more susceptible to parasite resistance
than an extract with possibly many active compounds. A
number of other extracts from medicinal plants used
in Cameroon have also been shown to exhibit anti-
Onchocerca activity [25,26].
Although the essential oil from C. articulatus was
moderately cytotoxic on monkey kidney cells, in the
acute toxicity studies none of six mice died at the limit
dose of 2000 mg/kg body weight, and only one was trau-
matized, probably by the drug administration procedure.
This safety profile may imply a detoxification mecha-
nism in the liver or kidneys in vivo. The finding in mice
also lends credence to the ethnopharmacologically
observed lack of toxicity or adverse effects in humans, at
least in the short term.Conclusions
The essential oil from the roots/rhizomes of C. articulatus
is active against O. ochengi microfilariae and adult worms,
hence may provide a source of new anti-filarial lead
compounds. The results obtained also support the use
of C. articulatus in traditional medicine for the treatment
of human onchocerciasis.
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